Advertisement

Topics

Aerpio Pharmaceuticals, Inc. Company Profile

04:07 EDT 19th June 2019 | BioPortfolio

Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The Company’s lead program, AKB‐9778, is a small molecule activator of the Tie2 pathway and is in clinical development for diabetic retinopathy.


News Articles [506 Associated News Articles listed on BioPortfolio]

Aerpio Pharmaceuticals to Present at the 18th Annual Needham Healthcare Conference

Aerpio Pharmaceuticals, Inc. (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, to...

Aerpio completes dosing in TIME-2b study of AKB-9778

Aerpio Pharmaceuticals has completed patient dosing in the Phase II TIME-2b clinical trial evaluating the efficacy and safety of AKB-9778...Read More... The post Aerpio completes dosing in TIME-2b stu...

Aerpio Pharmaceuticals: Eye Spy An Opportunity

Aerpio Shares Plummet after Lead Candidate Fails Phase IIb Diabetic Retinopathy Trial

Aerpio Pharmaceuticals acknowledged the failure of its lead pipeline candidate in a Phase IIb trial in patients with moderate to severe non-proliferative diabetic retinopathy (NPDR), triggering a sell...

Aerpio Pharmaceuticals (ARPO) Investor Presentation - Slideshow

Aerpio Pharmaceuticals to Announce Fourth Quarter and Full Year 2018 Financial Results and Host Conference Call on Tuesday, March 5, 2019

Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, tod...

Aerpio Pharmaceuticals ($ARPO) Shares Plummet after Lead Candidate Fails Phase IIb Diabetic Retinopathy Trial: http://ow.ly/YP7h30o5s7G pic.twitter.com/UwBESZaXUa

Aerpio Pharmaceuticals ($ARPO) Shares Plummet after Lead Candidate Fails Phase IIb Diabetic Retinopathy Trial: http://ow.ly/YP7h30o5s7G  pic.twitter.com/UwBESZaXUa

Aerpio Pharmaceuticals ($ARPO) Shares Plummet after Lead Candidate Fails Phase IIb Diabetic Retinopathy Trial: http://ow.ly/YP7h30o5s7G pic.twitter.com/55YIatvyNI

Aerpio Pharmaceuticals ($ARPO) Shares Plummet after Lead Candidate Fails Phase IIb Diabetic Retinopathy Trial: http://ow.ly/YP7h30o5s7G  pic.twitter.com/55YIatvyNI

Drugs and Medications [0 Results]

None

PubMed Articles [152 Associated PubMed Articles listed on BioPortfolio]

Occurrence and distribution of pharmaceuticals in raw, finished, and drinking water from seven large river basins in China.

The occurrence of pharmaceuticals in the drinking water is a growing concern in China. In this study, we determined the concentration and distribution of 59 selected pharmaceuticals in raw, finished, ...

Insight into the distribution of pharmaceuticals in soil-water-plant systems.

Pharmaceuticals in agricultural soils originating from irrigation with treated wastewater and land-applied biosolids can enter field crops. However, little is known about the role of pore water in pla...

U.S. Emergency Department Visits Resulting From Nonmedical Use of Pharmaceuticals, 2016.

National data on morbidity from nonmedical use of pharmaceuticals are limited. This study used nationally representative, public health surveillance data to characterize U.S. emergency department visi...

Exposure and ecotoxicological risk assessment of mixtures of top prescribed pharmaceuticals in Swedish freshwaters.

Surface water concentrations of 54 pharmaceuticals were predicted for seven major Swedish rivers and the Stockholm City area basins using the STREAM-EU model. These surface water concentrations were u...

Simultaneous aqueous chlorination of amine-containing pharmaceuticals.

Amine-containing pharmaceuticals such as acetaminophen, diclofenac, and sulfamethoxazole are the most often detected pharmaceuticals in wastewater and other aquatic environments. Amine-containing phar...

Clinical Trials [236 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1371 Associated Companies listed on BioPortfolio]

Aerpio Pharmaceuticals, Inc.

Aerpio Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing first-in-class treatments for ocular diseases. The Company’s lead program, AKB‐9778, is ...

Aerpio Therapeutics

Aerpio Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on advancing innovative therapies for the treatment of diabetic eye disease and inflammatory bowel ...

Aerpio Therapeutics, Inc.

Aerpio Therapeutics, Inc. is a clinical‐stage biopharmaceutical company focused on advancing innovative therapies for the treatment of diabetic eye disease and inflammatory b...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Excaliard Pharmaceuticals, Inc.

Excaliard Pharmaceuticals, Inc., is a venture capital-funded biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration o...

More Information about "Aerpio Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Aerpio Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Aerpio Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Aerpio Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aerpio Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Aerpio Pharmaceuticals, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Diabetes
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...


Corporate Database Quicklinks



Searches Linking to this Company Record